Qaiser Bashir

Qaiser Bashir is a Professor at The University of Texas MD Anderson Cancer Center, specializing in hematology, oncology, and transplantation medicine. His research focuses on stem cell transplantation, hematological malignancies, and clinical immunology, with recent work exploring myeloablative conditioning regimens for high-risk myelodysplastic syndromes, pharmacokinetic-guided melphalan dosing in multiple myeloma, and graft-versus-host disease prophylaxis strategies. His latest publications examine individualized Evomela dosing, renal function impacts on autologous transplantation in AL amyloidosis, and lenalidomide maintenance post-transplant. A senior professor, he contributes extensively to optimizing transplantation outcomes and advancing therapeutic protocols for hematologic cancers.